OSAT yields 53.33% · PFE yields 6.13%● Live data
📍 OSAT pulled ahead of the other in Year 1
Combined, OSAT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSAT + PFE for your $10,000?
Orbsat Corp., together with its subsidiaries, provides mobile satellite services (MSS) solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and Internet of Things (IoT) connectivity services in the United States and internationally. Its solutions include satellite communications, IoT tracking, and Internet, as well as emergency locator beacons. The company also provides tracking and monitoring solutions using automatic identification system, 2G-5G, push-to-talk, and two-way radio technology; and sells MSS related equipment. In addition, it operates GTCTrack, a subscription-based mapping and tracking portal that provides cloud-based data visualization and management platform that allow managers to track, command, and control assets in near-real-time; and a short-term rental service for customers to use equipment for a limited time period. The company provides its solutions for businesses, governments, military, humanitarian organizations, and individual users to communicate, connect to internet, track and monitor remote assets and lone workers, or request SOS assistance via satellite. It offers its products and services directly to end users and reseller networks; operates e-commerce websites that offer a range of MSS products and solutions; and offers portable satellite voice, data, and tracking solutions through various third-party e-commerce storefronts. The company was formerly known as Orbital Tracking Corp and changed its name to Orbsat Corp. in August 2019. Orbsat Corp. was incorporated in 1997 and is headquartered in Aventura, Florida.
Full OSAT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.